Antigen presentation by clonally diverse CXCR5+ B cells to CD4 and CD8 T cells is associated with durable response to immune checkpoint inhibitors

By sjmartinez • July 12, 2023

Ding L, Sun L, Bu MT, Zhang Y, Scott LN, Prins RM, Su MA, Lechner MG, Hugo W. Antigen presentation by clonally diverse CXCR5+ B cells to CD4 and CD8 T cells is associated with durable response to immune checkpoint inhibitors. Front Immunol. 2023 Jun 26;14:1176994. doi: 10.3389/fimmu.2023.1176994. PMID: 37435085; PMCID: PMC10330698.

Tags: antigen presentation, B cell, checkpoint inhibitors, Dermatology, Endocrinology, immunotherapy, interferon gamma pathway, melanoma, Publications, T cell, tertiary lymphoid structure (TLS)

Efficacy and safety of ME3183, an oral phosphodiesterase 4 inhibitor, in patients with plaque psoriasis

Papp KA, Armstrong AW, Koresawa T, Otake K, Hirata M, Kano A. Efficacy and safety of ME3183, an oral phosphodiesterase 4 inhibitor, in patients with[...]

Granulysin-high decidual NK cells in macaques and humans share signatures of immune defense

Prasanphanich NS, Protti G, Cappelletti M, Ma F, Pithia N, Dasenbrock A, Stanek J, Chougnet CA, Kallapur SG, Pellegrini M, Tilburgs T, Presicce P. Granulysin-high[...]

GLP-1RAs and cardiovascular risk reduction in hidradenitis suppurativa: A real-world cohort study

Chou PP, Jeong C, Ma E, Roberts AM, Katz A, Nong Y, Yan MJ, Johnsen N, Armstrong AW. GLP-1RAs and cardiovascular risk reduction in hidradenitis[...]